The Effect of Sevoflurane and Desflurane on Clara Cell Protein on the Lung

NACompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

November 25, 2020

Primary Completion Date

June 15, 2021

Study Completion Date

June 20, 2021

Conditions
Inhalation AnesthesiaLung Injury
Interventions
DRUG

Sevoflurane

In the sevoflurane group (n = 25), after the induction of anesthesia with 2 mg / kg propofol and 1 µg / kg remifentanyl, rocuronium 0.6 mg / kg will be given for intubation. In this group, the Sevoflurane concentration will be adjusted between 1-2%, the BIS value will be 40-60, and it will be inhaled with an air / O2 mixture to be FiO2: 0.4.

DRUG

Desflurane

In the desflurane group (n = 25), after induction of anesthesia with 2 mg / kg propofol and 1 µg / kg remifentanyl, rocuronium 0.6 mg / kg will be given for intubation. In this group, Desflurane concentration will be adjusted between 6-8%, BIS value will be 40-60 and it will be inhaled with a mixture of air / O2 mixture to be FiO2: 0.4.

DRUG

Propofol

In the propofol-remifentanyl group (n = 25), rocuronium 0.6 mg / kg will be administered for intubation after 2 mg / kg propofol and 1 µg / kg remifentanil. Maintenance of anesthesia will be adjusted to be between 10 mg / kg / h for the first 10 minutes, 8 mg / kg / h for the following 10 minutes, and then by 6 mg / kg / h propofol infusion, with the BIS value between 40-60. Patients in this group will be inhaled with a mixture of air / O2 to be FiO2: 0.4. Inhalation anesthetics will not be used in this group.

Trial Locations (1)

44250

Inonu University, Malatya

All Listed Sponsors
lead

Inonu University

OTHER

NCT04645316 - The Effect of Sevoflurane and Desflurane on Clara Cell Protein on the Lung | Biotech Hunter | Biotech Hunter